Literature DB >> 16138010

Inhibition of the ATR/Chk1 pathway induces a p38-dependent S-phase delay in mouse embryonic stem cells.

Ludmila Jirmanova1, Dmitry V Bulavin, Albert J Fornace.   

Abstract

Ataxia-telangiectasia mutated (ATM) and ATM- and Rad3-related (ATR) kinases, family members of the PI-3 kinase related proteins, play a key role in checkpoint activation and maintenance of genomic stability following DNA damage. We have used wild type (WT) and p38alpha-deficient mouse embryonic stem (ES) cells to investigate the role of ATR and ATM kinases during embryonic cell cycle. We have found that inhibition of ATR and ATM kinases with caffeine or Chk1 with UCN-01, results in activation of a p38-dependent intra-S-phase checkpoint and activation of apoptosis in ES cells. However, wortmannin at a concentration, that inhibits ATM kinase but not ATR kinase, did not affect cell cycle progression. Furthermore, the presence of caffeine results in activation of p38 kinase, accumulation of p21/Waf1 in a complex with Cdk2 and decrease of Cdk2 kinase activity. In contrast, caffeine-treated p38alpha-/- ES cells show less apoptosis, and fail to trigger an effective S-phase checkpoint and accumulation of p21/Waf1. We conclude that ATR kinase activity is essential for normal cell cycle progression of exponentially proliferating mouse ES cells even in the absence of exogenous DNA damage, and ATR deregulation triggers p38alpha-dependent cell-cycle checkpoint and apoptotic responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138010     DOI: 10.4161/cc.4.10.2055

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  14 in total

Review 1.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 2.  Molecular mechanisms controlling the cell cycle in embryonic stem cells.

Authors:  Essam M Abdelalim
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

3.  Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-renewal.

Authors:  Yan-Lin Guo; Samujjwal Chakraborty; Suja S Rajan; Rouxing Wang; Faqing Huang
Journal:  Stem Cells Dev       Date:  2010-09       Impact factor: 3.272

4.  Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX.

Authors:  D K Walters; X Wu; R C Tschumper; B K Arendt; P M Huddleston; K J Henderson; A Dispenzieri; D F Jelinek
Journal:  Leukemia       Date:  2011-05-13       Impact factor: 11.528

5.  Three Observations That Have Changed Our Understanding of Cyclin D1 and p27 in Cell Cycle Control.

Authors:  Dennis W Stacey
Journal:  Genes Cancer       Date:  2010-12

6.  Regulation of PCNA polyubiquitination in human cells.

Authors:  Jan Brun; Roland K Chiu; Bradly G Wouters; Douglas A Gray
Journal:  BMC Res Notes       Date:  2010-03-30

7.  Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle progression.

Authors:  Masahiro Hitomi; Ke Yang; Andrew W Stacey; Dennis W Stacey
Journal:  Mol Cell Biol       Date:  2008-07-07       Impact factor: 4.272

8.  Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).

Authors:  Yaohui Wang; Yuchan Wang; Yan Xu; Wenyan Tong; Tingting Pan; Jianhua Li; Shuhui Sun; Junjie Shao; Huanping Ding; Tetsuya Toyoda; Zhenghong Yuan
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

9.  Syndecan-3 and Notch cooperate in regulating adult myogenesis.

Authors:  Addolorata Pisconti; D D W Cornelison; Hugo C Olguín; Tiffany L Antwine; Bradley B Olwin
Journal:  J Cell Biol       Date:  2010-08-09       Impact factor: 10.539

10.  DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells.

Authors:  XiaoQi Wang; Vincent C H Lui; Ronnie T P Poon; Ping Lu; Randy Y C Poon
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.